dalteparin has been researched along with Leukemia in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chojnowski, K | 1 |
| Treliński, J | 1 |
| Wawrzyniak, E | 1 |
| Robak, T | 1 |
| Vignoli, A | 1 |
| Marchetti, M | 1 |
| Russo, L | 1 |
| Cantalino, E | 1 |
| Diani, E | 1 |
| Bonacina, G | 1 |
| Falanga, A | 1 |
1 trial available for dalteparin and Leukemia
| Article | Year |
|---|---|
The influence of low molecular weight heparin on the intravascular activation of the coagulation system in patients with acute leukemia during induction chemotherapy--report of a prospective randomized study.
Topics: Acute Disease; Anticoagulants; Blood Coagulation; Disseminated Intravascular Coagulation; Humans; Le | 2002 |
1 other study available for dalteparin and Leukemia
| Article | Year |
|---|---|
LMWH bemiparin and ULMWH RO-14 reduce the endothelial angiogenic features elicited by leukemia, lung cancer, or breast cancer cells.
Topics: Angiogenesis Inhibitors; Breast Neoplasms; Cell Line, Tumor; Endothelial Cells; Female; Fibroblast G | 2011 |